Sustained androgen receptor (AR) signaling is the major driver of castration-resistant prostate cancer (CRPC) and promotes prostate cancer development through the regulation of not only transcription networks but also genomic stability and DNA repair (Mills, 2014; Watson et al., 2015). The gene discussed is AR; the disease is prostate cancer.